Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma

Clinical Cancer Research

Volumn 15, Issue 21, 2009, Pages 6529-6540

  Egloff, Ann Marie ^a   Rothstein, Mary E ^a   Seethala, Raja ^a   Siegfried, Jill M ^a   Grandis, Jennifer Rubin ^a   Stabile, Laura P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHO MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; ESTROGENS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 70350743117     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0862     Document Type: Article

References (50)

1. Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-7356 (Pubitemid 36025259)
2. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-832 (Pubitemid 28280548)
3. Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980-1987 (Pubitemid 46606387)
4. Cohen EE, Kane MA, List MA, et al. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2005;11: 8418-8424 (Pubitemid 41746956)
5. Soulieres D, Senzer NN, Vokes EE, Hidalgo M, Agarwala SS, Siu LL. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 2004;22: 77-85. (Pubitemid 41095117)
6. Burtness BGM, Flood W, Mattar B, Forastiere AA, Eastern Cooperative Oncology Group. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/ recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005;23:8646-8654 (Pubitemid 46211507)
7. Crombet T, Osorio M, Cruz T, et al. Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients. J Clin Oncol 2004;22:1646-1654 (Pubitemid 41079803)
8. Marquez-Garban DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 2007;72:135-143 (Pubitemid 46273500)
9. Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005;65:1459-1470 (Pubitemid 40270175)
10. Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M, Akiyoshi T. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 1990;50:7212-7215
11. Utsumi Y, Nakamura T, Nagasue N, Kubota H, Harada T, Morikawa S. Effect of 17 β-estradiol on the growth of an estrogen receptor-positive human esophageal carcinoma cell line. Cancer 1991;67:2284-2289
12. Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J. EGFR, HER2, and HER3 expression in laryngeal primary tumors and corresponding metastases. Ann Surg Oncol 2008;15: 1193-1201
13. Dassonville O, Formento JL, Francoual M, et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 1993;11:1873-1878 (Pubitemid 23304610)
14. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993;53:3579-3584
15. Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006;24:2666-2672 (Pubitemid 46622088)
16. Rogers SJ, Harrington KJ, Rhys-Evans P, P OC, Eccles SA. Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 2005;24:47-69. (Pubitemid 40576063)
17. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F. ER β inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001;142: 4120-4130 (Pubitemid 32802685)
18. Hou YF, Yuan ST, Li HC, et al. ERβ exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 2004;23:5799-5806 (Pubitemid 39093025)
19. Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51: 55-67. (Pubitemid 38781751)
20. Sacks PG, Parnes SM, Gallick GE, et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res 1988; 48:2858-2866 (Pubitemid 18137762)
21. Riser BL, Mitra R, Perry D, Dixit V, Varani J. Monocyte killing of human squamous epithelial cells: role for thrombospondin. Cancer Res 1989; 49:6123-6129 (Pubitemid 19274179)
22. Lin CJ, Grandis JR, Carey TE, et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck 2007;29:163-188 (Pubitemid 46167784)
23. Peterson WD, Jr., Stulberg CS, Simpson WF. A permanent heteroploid human cell line with type B glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1971;136:1187-1191
24. Stabile LP, Davis AL, Gubish C, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res 2002;62:2141-2150 (Pubitemid 34408463)
25. Paech K, Webb P, Kuiper GG, et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites [see comment]. Science 1997; 277:1508-1510 (Pubitemid 27449239)
26. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999;402:884-888 (Pubitemid 30017171)
27. Zhang Q, Thomas SM, Xi S, et al. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Cancer Res 2004;64:6166-6173 (Pubitemid 39129418)
28. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Can Res 1998;58:5221-5230 (Pubitemid 28521186)
29. Yang Z, Bagheri-Yarmand R, Wang RA, et al. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells. Clin Cancer Res 2004;10:658-667 (Pubitemid 38174006)
30. Grandis JR, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996; 78:1284-1292 (Pubitemid 26303896)
31. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261-269
32. Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007;121:1813-1820 (Pubitemid 47417302)
33. Moggs JG, Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2001;2:775-781 (Pubitemid 32982744)
34. Somers KD, Koenig M, Schechter GL. Growth of head and neck squamous cell carcinoma in nude mice: potentiation of laryngeal carcinoma by 17 β-estradiol. J Natl Cancer Inst 1988;80:688-691 (Pubitemid 18168329)
35. Ishida H, Wada K, Masuda T, et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci 2007;98: 636-643 (Pubitemid 46563438)
36. Grenman R, Virolainen E, Shapira A, Carey T. In vitro effects of tamoxifen on UM-SCC head and neck cancer cell lines: correlation with the estrogen and progesterone receptor content. Int J Cancer 1987;39:77-81.
37. Schuller DE, Abou-Issa H, Parrish R. Estrogen and progesterone receptors in head and neck cancer. Arch Otolaryngol 1984;110:725-727 (Pubitemid 15207699)
38. Lukits J, Remenar E, Raso E, Ladanyi A, Kasler M, Timar J. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol 2007;30:155-160
39. Ferguson BJ, Hudson WR, McCarty KS, Jr. Sex steroid receptor distribution in the human larynx and laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1987;113:1311-1315
40. Hagedorn HG, Nerlich AG. Analysis of sex-hormone- receptor expression in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2002;259:205-210 (Pubitemid 34437983)
41. Virolainen E, Vanharanta R, Carey TE. Steroid hormone receptors in human squamous carcinoma cell lines. Int J Cancer 1984;33:19-25. (Pubitemid 14223228)
42. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 2007;110: 1593-1601 (Pubitemid 47463075)
43. Muscat JE, Richie JP, Jr., Thompson S, Wynder EL. Gender differences in smoking and risk for oral cancer. Cancer Res 1996;56:5192-5197 (Pubitemid 26383035)
44. Cheng YS, Mues G, Wood D, Ding J. Aromatase expression in normal human oral keratinocytes and oral squamous cell carcinoma. Arch Oral Biol 2006;51:612-620 (Pubitemid 43849638)
45. Kawai H, Ishii A, Washiya K, et al. Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res 2005;25:4693-4698 (Pubitemid 41729532)
46. Kawai H, Ishii A, Washiya K, et al. Estrogen receptor α and β are prognostic factors in non-small cell lung cancer. Clin Cancer Res 2005;11: 5084-5089 (Pubitemid 41003691)
47. Skov BG, Fischer BM, Pappot H. Oestrogen receptor β over expression in males with non-small cell lung cancer is associated with better survival. Lung Cancer 2008;59:88-94.
48. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7.2 (Pubitemid 41507685)
49. Dougherty SM, Mazhawidza W, Bohn AR, et al. Gender difference in the activity but not expression of estrogen receptors α and β in human lung adenocarcinoma cells. Endocr Relat Cancer 2006;13:113-134
50. Yarden RI, Wilson MA, Chrysogelos SA. Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth. J Cell Biochem Suppl 2001;Suppl 36:232-246